2seventy bio, Inc. (NASDAQ:TSVT) Given Average Recommendation of “Reduce” by Analysts
Shares of 2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) have received an average rating of “Reduce” from the five ratings firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating and four have issued a hold rating on the company. The average 12 month price […]
Shares of 2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) have received an average rating of “Reduce” from the five ratings firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating and four have issued a hold rating on the company. The average 12 month price […]
